Core Positions on Drug Pricing: The BMC takes this opportunity to reiterate positions regarding drug pricing and related regulations, as follows: • Canada needs effective and balanced pharmaceutical pricing regulations which contribute to sustaining and improving the health and wellbeing of current and future patients. [...] Adopt effective and efficient frameworks and systems to support patient care The broad regulation of pharmaceuticals, including regarding pricing, must be efficient and not duplicative and prolonged due to redundant and overlapping mandates. [...] • Leadership at the PMPRB, and indeed all agencies involved in critical healthcare policy, must commit to understanding and prioritizing patient needs and recognize the value that patients and their representatives bring to deliberations regarding drafting and supporting health policy. [...] 3 www.bestmedicinescoalition.org • A holistic and value-based approach to patient engagement must be adopted, with opportunities for input and involvement embedded in the structure and processes of the PMPRB and any other agency involved in shaping health care systems and delivering care to patients. [...] The following standing goals drive the BMC’s advocacy and inform its positions: • Effective models for meaningful, proactive, and impactful patient engagement in health and pharmaceutical policy development, recommendations and decision making, where patients and patient organizations are recognized as legitimate and integral contributors and patient- informed evidence is valued and incorporated.
- Pages
- 5
- Published in
- Canada
